Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Holiday Inn London - Regent's Park

Feb 01, 2016 8:00 AM - Feb 05, 2016 1:00 PM

Carburton Street , London, W1W 5EE, United Kingdom

Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.

TOPIC 2 SESSION 2: Preparation of Development Safety Update Reports (DSURs)

Session Chair(s)

Gaby L. Danan, MD, PHD

Gaby L. Danan, MD, PHD

Pharmacovigilance Expert, GLD, France

Phil  Tregunno

Phil Tregunno

Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Vicki  Edwards, RPH

Vicki Edwards, RPH

Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom

Preparation of Development Safety Update Reports (DSURs)

Margaret Anne Walters

Margaret Anne Walters

Deputy EU Qualified Person for Pharmacovigilance, Merck, Sharp & Dohme Ltd, United Kingdom

Preparation of Development Safety Update Reports (DSURs)

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.